What Does the Street Think About Moderna, Inc. (MRNA)?

Moderna, Inc. (NASDAQ:MRNA) is one of the best healthcare stocks under $50 to invest in. Morgan Stanley reiterated a Hold rating on Moderna, Inc. (NASDAQ:MRNA) on February 2, setting a price target of $28.00. In a separate development, Moderna, Inc. (NASDAQ:MRNA) announced on January 29 a strategic collaboration with Recordati for the advancement of the former’s investigational propionic acidemia therapeutic, mRNA-3927, through the final stages of clinical development and global commercialization upon appr ...